Cite Filings / FULC / 0001193125-26-352345
Feed Companies Filings Check
Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

Fulcrum Therapeutics, Inc. · Filed 2026-08-14 · Acc 0001193125-26-352345

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

  • 2026-08-17 425 Prospectus/Communication re Business Combination
  • 2026-08-17 425 Prospectus/Communication re Business Combination
  • 2026-08-17 425 Prospectus/Communication re Business Combination
  • 2026-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-08-14 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G · ADAR1 Capital Management, LLC 8.7%
  2. 2026-11-16 SCHEDULE 13G/A · EcoR1 Capital, LLC 8.9%
  3. 2026-11-13 SCHEDULE 13G/A · Nantahala Capital Management, LLC 8.62%
  4. 2026-11-13 SCHEDULE 13G/A · Montanova Capital, LLC 0%
Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…